ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.63
      -0.18%
      Bitcoin
      65,093.90
      -0.07%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Corbus Pharmaceuticals Holdings Inc (CRBP)

      7. Corbus Pharmaceuticals Holdings Inc (CRBP) News

      CRBP

      Corbus Pharmaceuticals (CRBP)

      Corbus Pharmaceuticals Holdings Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:CRBP
      DateTimeSourceHeadlineSymbolCompany
      11/03/20208:05AMGlobeNewswire Inc.Corbus Pharmaceuticals to Report Third Quarter Results on November 10, 2020NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
      10/23/20208:05AMGlobeNewswire Inc.Corbus Pharmaceuticals Announces Presentation of Data from its Phase 2b Study in Cystic Fibrosis at NACFC 2020NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
      10/21/20208:05AMGlobeNewswire Inc.Corbus Pharmaceuticals Announces Three Lenabasum Abstracts to be Presented at ACR Convergence 2020NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
      10/13/20203:27PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
      10/08/20209:23AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
      10/08/20208:05AMGlobeNewswire Inc.Corbus Pharmaceuticals Announces Corporate Restructuring and Pipeline Portfolio UpdatesNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
      10/06/20208:33AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
      10/06/20207:05AMGlobeNewswire Inc.Corbus Pharmaceuticals Announces Phase 2b Study of Lenabasum for Treatment of Cystic Fibrosis Did Not Meet Primary EndpointNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
      09/25/20208:40AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
      09/15/20208:45AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
      09/08/20208:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
      09/08/20207:05AMGlobeNewswire Inc.Corbus Pharmaceuticals Announces Topline Results from RESOLVE-1 Phase 3 Study of Lenabasum for Treatment of Systemic Sclerosi...NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
      08/31/20205:32PMEdgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
      08/07/202011:37AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
      08/07/20206:07AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
      08/07/20206:07AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
      08/06/20205:28PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
      08/06/20207:36AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
      08/06/20207:05AMGlobeNewswire Inc.Corbus Pharmaceuticals Reports Second Quarter Financial Results and Corporate UpdatesNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
      08/05/20209:25AMGlobeNewswire Inc.Corbus Pharmaceuticals Completes Enrollment in DETERMINE Phase 3 Study of Lenabasum for Treatment of DermatomyositisNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
      08/03/20208:05AMGlobeNewswire Inc.Corbus Pharmaceuticals to Present at Two Upcoming Investor ConferencesNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
      07/30/20208:05AMGlobeNewswire Inc.Corbus Pharmaceuticals to Report Second Quarter Results on August 6, 2020 NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
      07/29/20208:22AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
      07/29/20208:05AMGlobeNewswire Inc.Corbus Pharmaceuticals Strengthens Balance Sheet with up to $121 Million in New CapitalNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
      07/08/20208:35AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
      07/08/20208:33AMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
      07/08/20208:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
      07/08/20208:05AMGlobeNewswire Inc.Corbus Pharmaceuticals Appoints George Golumbeski, Ph.D., to Board of DirectorsNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
      06/29/20208:05AMGlobeNewswire Inc.Corbus Pharmaceuticals Presents Data Demonstrating ACR CRISS Score Reflects Patient-Reported Outcomes at 6th Systemic Scleros...NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
      06/22/20208:05AMGlobeNewswire Inc.Corbus Pharmaceuticals Reports Last Subject Visit in Phase 2b Study of Lenabasum for Treatment of Cystic FibrosisNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
       Showing the most relevant articles for your search:NASDAQ:CRBP